Omega-3 Market – Global Forecast to 2030
오메가-3 시장 – 유형(DHA, EPA 및 ALA), 출처(해양 및 식물), 응용 분야(식이 보충제, 기능성 식품 및 음료, 제약품, 영유아용 조제분유 및 애완동물 사료), 형태, 제조 기술 및 지역 – 2030년까지의 세계 예측
Omega-3 Market by Type (DHA, EPA, & ALA), Source (Marine & Plant), Application (Dietary Supplements, Functional Foods & Beverages, Pharmaceuticals, Infant Formulas, and Pet Food & Feed), Form, Manufacturing Technology, and Region – Global Forecast to 2030
| 조사회사 | MarketsandMarkets |
| 출판년월 | 2025년10월 |
| 페이지 수 | 314 |
| 도표 수 | 382 |
| 라이센스 | Single User License |
| 가격 | USD 4,950 |
| 구성 | 영문조사보고서 |
오메가-3 시장은 2025년에 43억 6,220만 달러 규모로 추산되며, 2030년까지 연평균 성장률 12.2%로 77억 5,640만 달러에 이를 것으로 전망됩니다.
오메가-3 시장은 심혈관 건강, 인지 기능, 시력, 관절 건강, 영유아 뇌 발달에 있어 EPA와 DHA의 역할에 대한 인식이 높아지고, 소비자들이 예방 건강 관리 및 기능성 영양에 대한 관심을 높이면서 상당한 성장세를 보이고 있습니다. 영유아용 조제분유 시장은 부모들 사이에서 인지 및 신체 발달을 위한 초기 영양의 중요성, 특히 DHA와 기타 필수 영양소의 역할에 대한 인식이 높아지고, 유럽, 북미, 중국 등 일부 지역에서 영유아용 조제분유에 DHA 강화를 의무화하거나 권장하는 규제 및 권고에 힘입어 폭발적인 성장을 보이고 있습니다. 그러나 높은 연구개발 비용과 불안정한 어유 가격은 오메가-3 시장 성장에 걸림돌이 될 것으로 예상됩니다.
이 조사 보고서는 오메가-3 시장을 유형(도코사헥사엔산(DHA), 에이코사펜타엔산(EPA), 알파리놀렌산(ALA)), 공급원(해양[어류, 조류, 크릴 및 기타 해양 자원]과 식물[견과류 및 씨앗류, 식물성 기름]), 응용 분야(식이 보충제, 기능성 식품 및 음료, 의약품, 영유아용 조제분유, 애완동물 사료 및 사료), 형태(건조 및 액상), 제조 기술(정성적)(추출, 정제 및 정제, 농축 및 전환, 캡슐화 및 안정화, 발효 및 생명 공학), 지역(북미, 유럽, 아시아 태평양, 남미 및 기타 세계)으로 분류합니다.
본 보고서는 오메가-3 성분의 성장에 영향을 미치는 주요 요인(동인, 제약, 과제, 기회 등)에 대한 자세한 정보를 다룹니다. 주요 업계 참여 기업에 대한 심층 분석을 통해 사업, 서비스, 주요 전략, 계약, 파트너십, 협정, 제품 출시, 인수합병(M&A), 그리고 오메가-3 시장과 관련된 최근 동향에 대한 통찰력을 제공합니다. 본 보고서는 오메가-3 시장 생태계에서 유망한 스타트업 기업들의 경쟁 분석을 다룹니다. 또한, 기술 분석, 생태계 및 시장 매핑, 특허 및 규제 환경 등 산업별 동향을 다룹니다.
이 보고서는 시장 선도 기업/신규 진입 기업들에게 오메가-3 전체 및 하위 세그먼트의 매출 수치에 대한 가장 근사치 정보를 제공합니다. 이해관계자들이 경쟁 환경을 이해하고, 사업의 입지를 강화하고 적절한 시장 진출 전략을 수립하는 데 필요한 통찰력을 얻는 데 도움이 될 것입니다. 또한, 이 보고서는 이해관계자들이 시장의 흐름을 이해하고 주요 시장 동인, 제약, 과제, 그리고 기회에 대한 정보를 제공합니다.
Report Description
The omega-3 market is estimated to be USD 4,362.2 million in 2025 and is projected to reach USD 7,756.4 million by 2030, at a CAGR of 12.2%.
The omega-3 market is gaining significant traction, driven by the increasing recognition of the roles of EPA and DHA in cardiovascular health, cognitive function, vision, joint health, and infant brain development, as well as a growing consumer shift toward preventive healthcare and functional nutrition. The infant formula sector has witnessed explosive growth, driven by rising awareness among parents about the importance of early nutrition for cognitive and physical development, particularly the role of DHA and other essential nutrients, and regulatory mandates and recommendations in regions such as Europe, North America, and China requiring or encouraging DHA fortification in infant formula. However, high costs involved in R&D activities and unstable fish oil prices are expected to pose a challenge to the omega-3 market’s growth.
Disruptions in the omega-3 market may offer opportunities for players
The omega-3 market is undergoing fundamental shifts, opening up new opportunities for companies. One of the most significant changes is the shift toward sustainable and plant-based sources such as algal oil and fermentation-based omega-3, which eliminate fish oil supply concerns and resonate with vegan and green consumers. Regulatory updates, such as the mandatory fortification of DHA in infant nutrition and broader approvals for cardiovascular and cognitive well-being claims, are also driving steady demand in both developed and emerging markets. Meanwhile, technological advances such as microencapsulation are enhancing stability and flavor, allowing omega-3 to be incorporated in new food and beverage applications.
On the application front, Omega-3 is increasingly being used in pharmaceuticals, pet food, and aquaculture, apart from conventional supplements. Pharma-grade formulations for neurological and cardiovascular health are gaining momentum, while high-end pet food and fortified aquaculture feed are experiencing significant growth. Alongside growing demand for convenience formats of functional nutrition products (gummies, powders, RTDs) and increasing consumer spending on health supplement products in South America and the Asia Pacific, these trends are redefining the landscape of the market. Players who innovate in sourcing, product development, and sustainability have a good chance of securing growth in emerging markets.
The dietary supplement segment is projected to be one of the fastest-growing segments
The dietary supplement category is one of the major growth drivers for the omega-3 market as consumers place greater emphasis on preventive healthcare and turn to convenient solutions for heart, brain, eye, and joint well-being. Supported by regulatory approvals for health claims, supplements offer confidence and convenience, as advancements in delivery forms, such as softgels, gummies, and powders, make them attractive to people of all ages. This synergy of health consciousness, aging population, and product creativity is driving robust and consistent demand for omega-3 in dietary supplements.
The liquid form of omega-3 is expected to hold a larger share of the omega-3 market
The majority of commercial omega-3 comes from fish oil, algal oil, and krill oil, which are naturally liquid forms and commonly used in dietary supplements, infant formula, functional foods, and pharmaceuticals. Liquids can accommodate higher purity, greater bioavailability, and simpler inclusion in soft gels, emulsions, and fortified liquid food. While dry formulations (powders, microencapsulated Omega-3) are increasing as a result of uses in gummies, powders, and bakery applications, the liquid form continues to hold a significant market share as it is the most cost-efficient, mass-produced, and immediately applicable state across industries.
The Eicosapentaenoic Acid (EPA) segment is expected to grow at a significant rate
The EPA has been shown to benefit heart health, including reducing triglyceride levels, decreasing inflammation, and improving overall cardiovascular function. As awareness of these health benefits increases among consumers, there is a growing demand for omega-3 supplements and fortified foods and beverages containing EPA, which contributes to the expansion of the omega-3 market.
The US is estimated to dominate the North American omega-3 market during the forecast period
The US is one of the largest global markets for omega-3. The consumption of omega-3-based products and supplements has increased significantly due to rising consumer awareness of their various health benefits and their availability in the US market. The omega-3 consumption pattern in the US is driven toward categories such as capsules, dietary supplements, and infant formula. However, the country has one of the largest consumer markets in the world. Recently, the EPA/DHA (omega-3) ingredients sector has experienced a surge in product innovations, introducing new omega-3 variants and expanding the utilization of plant-based sources. As consumers increasingly prioritize the health of oceans, there is a growing demand for plant-based omega-3 ingredients within the dietary supplement sector.
In-depth interviews have been conducted with chief executive officers (CEOs), directors, and other executives from various key organizations operating in the omega-3 market.
- By Company Type: Tier 1–25%, Tier 2–45%, and Tier 3–30%
- By Designation: CXOs–25%, Managers–40%, Executives–35%
- By Region: North America–22%, Europe–28%, Asia Pacific–32%, South America–10% and Rest of the World–8%
Prominent companies in the market include BASF SE (Germany), Cargill, Incorporated (US), dsm-firmenich (Netherlands), ADM (US), Kerry Group plc (Ireland), Aker BioMarine (Norway), Croda International PLC (UK), Corbion (Netherlands), Pelagia AS (Norway), KD Pharma Group SA (Switzerland), GC Rieber (Norway), Cooke Aquaculture Inc. (Canada), GOLDEN OMEGA (Chile), Polaris (France), Btsa (Spain), KinOmega Biopharm Inc. (China), Rimfrost AS (Norway), Mara Renewables (Canada), Cellana Inc. (US), AlgaeCytes Limited (UK), and others.
Research Coverage
This research report categorizes the omega-3 market by type (Docosahexaenoic Acid (DHA), Eicosapentaenoic Acid (EPA), and Alpha-linolenic Acid (ALA)), source (marine [fish, algal, krill, and other marine sources] and plant [nuts & seeds and vegetable oils]), application (dietary supplements, functional foods & beverages, pharmaceuticals, infant formulas, and pet food and feed), form (dry and liquid), manufacturing technology (qualitative) (extraction, refining & purification, concentration & conversion, encapsulation & stabilization, and fermentation & biotechnology), and region (North America, Europe, Asia Pacific, South America, and Rest of the World).
The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of omega-3 ingredients. A thorough analysis of the key industry players has been done to provide insights into their business, services, key strategies, contracts, partnerships, agreements, product launches, mergers & acquisitions, and recent developments associated with the omega-3 market. This report covers the competitive analysis of upcoming startups in the omega-3 market ecosystem. Furthermore, the study covers industry-specific trends, including technology analysis, ecosystem & market mapping, and patent & regulatory landscapes, among others.
Reasons to Buy This Report
The report offers market leaders/new entrants information on the closest approximations of the revenue numbers for the overall omega-3 and subsegments. It will help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
The report provides insights into the following pointers:
- Analysis of key drivers (Rising adoption of algal oil and plant-based omega-3 (flaxseed, chia, canola) due to concerns over fish oil sustainability), restraints (lack of clarity among consumers about daily recommended intake and health claims), opportunities (increase in research for development of alternative sources to obtain omega-3), and challenges (highly unstable fish oil prices) influencing the growth of the omega-3 market
- Product Development/Innovation: Detailed insights on research & development activities and new product launches in the omega-3 market
- Market Development: Comprehensive information about lucrative markets—the report analyzes omega-3 across varied regions
- Market Diversification: Exhaustive information about new product sources, untapped geographies, recent developments, and investments in the omega-3 market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, brand/product comparison, and product footprints of leading players such as BASF SE (Germany), Cargill, Incorporated (US), dsm-firmenich (Netherlands), ADM (US), Kerry Group plc (Ireland), Aker BioMarine (Norway), Croda International PLC (UK), Corbion (Netherlands), Pelagia AS (Norway), KD Pharma Group SA (Switzerland), and other players in the omega-3 market.
Table of Contents
1 INTRODUCTION 29
1.1 STUDY OBJECTIVES 29
1.2 MARKET DEFINITION 29
1.3 STUDY SCOPE 30
1.3.1 MARKETS COVERED AND REGIONS CONSIDERED 30
1.3.2 INCLUSIONS AND EXCLUSIONS 31
1.3.3 YEARS CONSIDERED 32
1.3.4 CURRENCY CONSIDERED 32
1.3.5 UNITS CONSIDERED 33
1.4 STAKEHOLDERS 33
1.5 SUMMARY OF CHANGES 34
2 RESEARCH METHODOLOGY 35
2.1 RESEARCH DATA 35
2.1.1 SECONDARY DATA 35
2.1.1.1 Key data from secondary sources 36
2.1.2 PRIMARY DATA 36
2.1.2.1 Key data from primary sources 37
2.1.2.2 Breakdown of primary profiles 37
2.1.2.3 Key insights from industry experts 38
2.2 MARKET SIZE ESTIMATION 38
2.2.1 TOP-DOWN APPROACH 39
2.2.2 SUPPLY-SIDE ANALYSIS 40
2.2.3 BOTTOM-UP APPROACH (DEMAND SIDE) 40
2.3 DATA TRIANGULATION AND MARKET BREAKUP 42
2.4 RESEARCH ASSUMPTIONS 43
2.5 RESEARCH LIMITATIONS AND RISK ASSESSMENT 43
3 EXECUTIVE SUMMARY 44
4 PREMIUM INSIGHTS 48
4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN OMEGA-3 MARKET 48
4.2 NORTH AMERICA: OMEGA-3 MARKET, BY SOURCE AND COUNTRY 48
4.3 OMEGA-3 MARKET, BY TYPE 49
4.4 OMEGA-3 MARKET, BY APPLICATION 49
4.5 OMEGA-3 MARKET, BY SOURCE AND REGION 50
4.6 OMEGA-3 MARKET: REGIONAL SNAPSHOT 51
5 MARKET OVERVIEW 52
5.1 INTRODUCTION 52
5.2 MACROECONOMIC INDICATORS 52
5.2.1 PREVENTIVE HEALTHCARE EXPENDITURE 52
5.2.2 GROWING GERIATRIC POPULATION 53
5.3 MARKET DYNAMICS 54
5.3.1 DRIVERS 55
5.3.1.1 Growing consumer awareness regarding health benefits 55
5.3.1.2 Increasing use in food and feed products 56
5.3.1.2.1 Rising demand for mother and infant nutrition products 56
5.3.1.2.2 Mandatory inclusion of algal DHA in infant formula 57
5.3.1.2.3 Growth focus of food processing companies on fortification 57
5.3.1.2.4 Increasing applications in pet food and feed 58
5.3.1.3 Shift toward pharmaceutical-grade high-concentrate omega-3 oils in developed markets 59
5.3.1.4 Emergence of innovative production technologies 59
5.3.2 RESTRAINTS 61
5.3.2.1 Declining fish oil supply due to sustainability issues in fisheries 61
5.3.2.2 Lack of clarity on daily intake recommendations and health claims 62
5.3.3 OPPORTUNITIES 62
5.3.3.1 Increasing research on alternative sources 62
5.3.3.1.1 Rising consumer demand for plant-based products 64
5.3.3.1.2 Growing focus on microalgae-based omega-3 production 64
5.3.3.1.3 Side effects and allergies related to fish-based products 65
5.3.3.2 Favorable regulatory environment 65
5.3.3.3 Integration of microencapsulation technology 65
5.3.4 CHALLENGES 66
5.3.4.1 High costs involved in R&D activities 66
5.3.4.2 Volatility in fish oil prices 67
5.3.4.3 Instability of omega-3 oils 67
5.4 IMPACT OF GEN AI ON FOOD & BEVERAGE INGREDIENTS/ADDITIVES 68
5.4.1 USE OF GEN AI IN FOOD & BEVERAGE INGREDIENTS/ADDITIVES 69
5.4.2 CASE STUDIES FOR GENERATIVE AI IN FOOD & BEVERAGE INGREDIENTS/ADDITIVES 70
5.4.2.1 Kerry Trendspotter leveraged AI and ML to analyze consumer-generated social media content, identifying and predicting food trends 70
5.4.2.2 IFF partners with Salus Optima to create personalized nutrition platform using AI to offer customized dietary recommendations based on metabolic health 70
5.4.2.3 Ingredion utilized cloud-based data analytics, AI, and cloud technology to address challenges in F&B industry 71
5.4.3 IMPACT OF AI/GENERATIVE AI ON OMEGA-3 MARKET 72
5.4.4 ADJACENT ECOSYSTEM WORKING ON GENERATIVE AI 73
6 INDUSTRY TRENDS 74
6.1 INTRODUCTION 74
6.2 IMPACT OF 2025 US TARIFF – OMEGA-3 MARKET 74
6.2.1 INTRODUCTION 74
6.2.2 KEY TARIFF RATES 75
6.2.3 DISRUPTION IN OMEGA-3 MARKET 75
6.2.4 PRICE IMPACT ANALYSIS 76
6.2.5 IMPACT ON COUNTRY/REGION 77
6.2.5.1 US 77
6.2.5.2 Europe 78
6.2.5.3 China 78
6.2.6 IMPACT ON DIFFERENT APPLICATIONS 78
6.3 VALUE CHAIN ANALYSIS 79
6.3.1 RESEARCH AND PRODUCT DEVELOPMENT 80
6.3.2 SOURCING 80
6.3.3 PRODUCTION AND PROCESSING 81
6.3.4 DISTRIBUTION 81
6.3.5 MARKETING AND SALES 81
6.3.6 END USERS 81
6.4 TRADE ANALYSIS 81
6.4.1 IMPORT SCENARIO OF HS CODE 1504 82
6.4.2 EXPORT SCENARIO OF HS CODE 1504 83
6.5 TECHNOLOGY ANALYSIS 84
6.5.1 KEY TECHNOLOGIES 84
6.5.1.1 Molecular distillation 84
6.5.1.2 Supercritical CO₂ extraction 84
6.5.1.3 Algae fermentation 85
6.5.2 COMPLEMENTARY TECHNOLOGIES 85
6.5.2.1 Stabilization & antioxidant technologies 85
6.5.2.2 Microencapsulation 86
6.5.3 ADJACENT TECHNOLOGIES 86
6.5.3.1 Precision fermentation 86
6.5.3.2 Synthetic biology & bioprocess engineering 86
6.6 PRICING ANALYSIS 87
6.6.1 AVERAGE SELLING PRICE OF OMEGA-3 FINISHED PRODUCTS, BY PRODUCT TYPE 87
6.6.2 AVERAGE SELLING PRICE TREND, BY REGION 88
6.7 ECOSYSTEM ANALYSIS 89
6.7.1 DEMAND SIDE 89
6.7.2 SUPPLY SIDE 90
6.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 92
6.9 PATENT ANALYSIS 93
6.10 KEY CONFERENCES AND EVENTS, 2025–2026 95
6.11 REGULATORY LANDSCAPE 96
6.11.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 96
6.11.2 REGULATIONS 98
6.11.2.1 North America 98
6.11.2.1.1 US 98
6.11.2.1.2 Canada 99
6.11.2.2 Europe 99
6.11.2.3 Asia Pacific 99
6.11.2.3.1 China 99
6.11.2.3.2 Japan 100
6.11.2.3.3 India 100
6.11.2.4 South America 100
6.11.2.4.1 Brazil 100
6.11.2.4.2 Argentina 101
6.11.2.4.3 Chile 101
6.11.2.5 Rest of the World 101
6.11.2.5.1 South Africa 101
6.11.2.5.2 UAE 101
6.12 PORTER’S FIVE FORCES ANALYSIS 102
6.12.1 INTENSITY OF COMPETITIVE RIVALRY 103
6.12.2 BARGAINING POWER OF SUPPLIERS 103
6.12.3 BARGAINING POWER OF BUYERS 103
6.12.4 THREAT OF SUBSTITUTES 103
6.12.5 THREAT OF NEW ENTRANTS 104
6.13 KEY STAKEHOLDERS AND BUYING CRITERIA 104
6.13.1 KEY STAKEHOLDERS IN BUYING PROCESS 104
6.13.2 BUYING CRITERIA 105
6.14 CASE STUDY ANALYSIS 106
6.14.1 VERAMARIS: PIONEERING SUSTAINABLE OMEGA-3 SOLUTIONS IN AQUACULTURE 106
6.14.2 MIALGAE INTRODUCED SUSTAINABLE OMEGA-3 PRODUCTION WITH INNOVATIVE BIOTECHNOLOGY 106
6.14.3 AKER BIOMARINE SUSTAINABLE OMEGA-3 PRODUCTION WITH INNOVATIVE BIOTECHNOLOGY 107
6.15 INVESTMENT AND FUNDING SCENARIO 107
7 OMEGA-3 MARKET, BY TYPE
(MARKET SIZE & FORECAST TO 2030 – USD MILLION) 108
7.1 INTRODUCTION 109
7.2 DOCOSAHEXAENOIC ACID 110
7.2.1 NEED FOR PROTECTION AGAINST ALZHEIMER’S DISEASE TO DRIVE DEMAND 110
7.3 EICOSAPENTAENOIC ACID 112
7.3.1 ABILITY TO REDUCE SUSCEPTIBILITY TO CARDIOVASCULAR DISEASES TO BOOST DEMAND 112
7.4 ALPHA-LINOLENIC ACID 113
7.4.1 GROWING POPULARITY AMONG VEGETARIANS AND VEGANS TO BOOST DEMAND 113
8 OMEGA-3 MARKET, BY SOURCE
(MARKET SIZE & FORECAST TO 2030- USD MILLION & KILOTONS) 115
8.1 INTRODUCTION 116
8.2 MARINE 117
8.2.1 NEED FOR HEALTHY FETAL DEVELOPMENT IN PREGNANT WOMEN TO DRIVE MARKET 117
8.2.2 FISH 120
8.2.2.1 Anchovy 121
8.2.2.2 Sardine 121
8.2.2.3 Mackerel 121
8.2.2.4 Other fish types 121
8.2.3 ALGAE 122
8.2.3.1 Schizochytrium sp. 122
8.2.3.2 Crypthecodinium cohnii 123
8.2.3.3 Nannochloropsis sp. 123
8.2.3.4 Other algae types 123
8.2.4 KRILL 123
8.2.5 OTHER MARINE SOURCES 124
8.3 PLANT 125
8.3.1 GROWING USE OF FLAX SEEDS FOR CANCER PREVENTION TO BOOST DEMAND 125
8.3.2 NUTS & SEEDS 128
8.3.3 VEGETABLE OILS 129
9 OMEGA-3 MARKET, BY APPLICATION
(MARKET SIZE & FORECAST TO 2030 – USD MILLION) 130
9.1 INTRODUCTION 131
9.2 DIETARY SUPPLEMENTS 132
9.2.1 GROWING IMPORTANCE OF BALANCED AND NUTRITIOUS DIETS TO DRIVE DEMAND 132
9.3 FUNCTIONAL FOODS & BEVERAGES 133
9.3.1 ABILITY TO BOOST CARDIOVASCULAR HEALTH TO DRIVE DEMAND 133
9.3.2 DAIRY & DAIRY ALTERNATIVES 134
9.3.3 BAKERY & CEREAL PRODUCTS 135
9.3.4 CONFECTIONERY PRODUCTS 135
9.3.5 MEAT & MEAT PRODUCTS 135
9.3.6 BEVERAGES 135
9.3.7 OTHER FUNCTIONAL FOOD PRODUCTS 136
9.4 PHARMACEUTICALS 136
9.4.1 GROWING NEED TO LOWER ELEVATED TRIGLYCERIDE LEVELS TO DRIVE MARKET 136
9.5 INFANT FORMULAS 137
9.5.1 RISING CONSUMPTION OF OMEGA-3 DHA DURING PREGNANCY TO BOOST DEMAND 137
9.6 PET FOOD & FEED 138
9.6.1 GREATER EMPHASIS ON ENHANCING IMMUNITY IN PETS TO DRIVE MARKET 138
9.6.2 PET FOOD 139
9.6.3 ANIMAL FEED 139
10 OMEGA-3 MARKET, BY FORM
(MARKET SIZE & FORECAST TO 2030 – USD MILLION) 140
10.1 INTRODUCTION 141
10.2 DRY 142
10.2.1 ENCAPSULATED STABILITY MEETS VERSATILE APPLICATIONS 142
10.3 LIQUID 143
10.3.1 HIGH BIOAVAILABILITY AND EFFICACY TO FUEL DEMAND 143
11 OMEGA 3 MARKET, BY MANUFACTURING TECHNOLOGY 145
11.1 INTRODUCTION 145
11.2 EXTRACTION 145
11.2.1 REFINING & PURIFICATION 145
11.2.2 CONCENTRATION & CONVERSION 145
11.2.3 ENCAPSULATION & STABILIZATION 146
11.2.4 FERMENTATION & BIOTECHNOLOGY 146
12 OMEGA-3 MARKET, BY REGION
(MARKET SIZE & FORECAST TO 2030 – USD MILLION & KILOTONS) 147
12.1 INTRODUCTION 148
12.2 NORTH AMERICA 151
12.2.1 US 156
12.2.1.1 Growing incorporation of omega-3 in dietary supplements to drive market 156
12.2.2 CANADA 157
12.2.2.1 Increasing application in functional foods & beverages to boost market 157
12.2.3 MEXICO 159
12.2.3.1 Growing focus on heart disease prevention to drive market 159
12.3 EUROPE 161
12.3.1 GERMANY 165
12.3.1.1 Low fish consumption to boost demand for omega-3-based supplements 165
12.3.2 UK 166
12.3.2.1 Increasing focus on preventive healthcare and maintaining cognitive function into older age to drive market 166
12.3.3 FRANCE 168
12.3.3.1 Ongoing innovations to boost quality and stability of omega-3-rich oil formulation to drive market 168
12.3.4 NORWAY 169
12.3.4.1 Production of genetically modified canola to offer lucrative growth opportunities to market players 169
12.3.5 ITALY 171
12.3.5.1 High production of dietary supplements, functional food products, and beverages to boost market 171
12.3.6 SPAIN 172
12.3.6.1 Rising consumer awareness and dietary gaps to drive market 172
12.3.7 NETHERLANDS 174
12.3.7.1 Growing incidences of depression, autism, and ADHD to drive market 174
12.3.8 REST OF EUROPE 175
12.4 ASIA PACIFIC 177
12.4.1 CHINA 182
12.4.1.1 Increasing focus on product innovations and diversification to drive market 182
12.4.2 INDIA 184
12.4.2.1 Growing incidences of heart failure to drive market 184
12.4.3 JAPAN 185
12.4.3.1 Rising use of innovative formulation technology to create opportunities for omega-3 product manufacturers 185
12.4.4 AUSTRALIA & NEW ZEALAND 186
12.4.4.1 Government-led initiatives to increase awareness regarding omega-3 to drive market 186
12.4.5 REST OF ASIA PACIFIC 188
12.5 SOUTH AMERICA 190
12.5.1 BRAZIL 193
12.5.1.1 Rising demand for algal oils to drive market 193
12.5.2 ARGENTINA 195
12.5.2.1 Commercialization of omega-3 products to fuel market 195
12.5.3 REST OF SOUTH AMERICA 196
12.6 REST OF THE WORLD 197
12.6.1 AFRICA 201
12.6.1.1 Prevalence of undernutrition among pregnant women and children to drive market 201
12.6.2 MIDDLE EAST 202
12.6.2.1 Ongoing innovations in omega-3 products to drive market 202
13 COMPETITIVE LANDSCAPE 204
13.1 OVERVIEW 204
13.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2020–2024 204
13.3 REVENUE ANALYSIS 206
13.4 MARKET SHARE ANALYSIS 207
13.5 COMPANY VALUATION AND FINANCIAL METRICS 210
13.6 BRAND/PRODUCT COMPARISON 211
13.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 212
13.7.1 STARS 213
13.7.2 EMERGING LEADERS 213
13.7.3 PERVASIVE PLAYERS 213
13.7.4 PARTICIPANTS 213
13.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 215
13.7.5.1 Company footprint 215
13.7.5.2 Regional footprint 216
13.7.5.3 Source footprint 217
13.7.5.4 Type footprint 217
13.7.5.5 Application footprint 218
13.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 219
13.8.1 PROGRESSIVE COMPANIES 219
13.8.2 RESPONSIVE COMPANIES 219
13.8.3 DYNAMIC COMPANIES 219
13.8.4 STARTING BLOCKS 220
13.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 221
13.8.5.1 Detailed list of key startups/SMEs 221
13.8.5.2 Competitive benchmarking of key startups/SMEs 222
13.9 COMPETITIVE SCENARIO 223
13.9.1 PRODUCT LAUNCHES AND ENHANCEMENTS 223
13.9.2 DEALS 225
13.9.3 EXPANSIONS 230
14 COMPANY PROFILES 232
14.1 KEY PLAYERS 232
14.1.1 DSM-FIRMENICH 232
14.1.1.1 Business overview 232
14.1.1.2 Products/Solutions/Services offered 233
14.1.1.3 Recent developments 234
14.1.1.3.1 Product launches and enhancements 234
14.1.1.4 MnM view 234
14.1.1.4.1 Right to win 234
14.1.1.4.2 Strategic choices 234
14.1.1.4.3 Weaknesses and competitive threats 234
14.1.2 CARGILL, INCORPORATED 235
14.1.2.1 Business overview 235
14.1.2.2 Products/Solutions/Services offered 236
14.1.2.3 Recent developments 236
14.1.2.3.1 Deals 236
14.1.2.4 MnM view 237
14.1.2.4.1 Key strengths 237
14.1.2.4.2 Strategic choices 237
14.1.2.4.3 Weaknesses and competitive threats 237
14.1.3 BASF SE 238
14.1.3.1 Business overview 238
14.1.3.2 Products/Solutions/Services offered 239
14.1.3.3 MnM view 241
14.1.3.3.1 Key strengths 241
14.1.3.3.2 Strategic choices 241
14.1.3.3.3 Weaknesses and competitive threats 241
14.1.4 ADM 242
14.1.4.1 Business overview 242
14.1.4.2 Products/Solutions/Services offered 243
14.1.4.3 MnM view 244
14.1.4.3.1 Right to win 244
14.1.4.3.2 Strategic choices 244
14.1.4.3.3 Weaknesses and competitive threats 244
14.1.5 KERRY GROUP PLC 245
14.1.5.1 Business overview 245
14.1.5.2 Products/Solutions/Services offered 246
14.1.5.3 Recent developments 247
14.1.5.3.1 Deals 247
14.1.5.4 MnM view 247
14.1.5.4.1 Right to win 247
14.1.5.4.2 Strategic choices 247
14.1.5.4.3 Weaknesses and competitive threats 248
14.1.6 CORBION 249
14.1.6.1 Business overview 249
14.1.6.2 Products/Solutions/Services offered 250
14.1.6.3 Recent developments 251
14.1.6.3.1 Product launches and enhancements 251
14.1.6.3.2 Expansions 251
14.1.6.3.3 Other developments 252
14.1.6.4 MnM view 252
14.1.7 KD PHARMA GROUP SA 253
14.1.7.1 Business overview 253
14.1.7.2 Products/Solutions/Services offered 254
14.1.7.3 Recent developments 255
14.1.7.3.1 Deals 255
14.1.7.3.2 Expansions 256
14.1.7.4 MnM view 256
14.1.8 AKER BIOMARINE 257
14.1.8.1 Business overview 257
14.1.8.2 Products/Solutions/Services offered 258
14.1.8.3 Recent developments 259
14.1.8.3.1 Product launches and enhancements 259
14.1.8.3.2 Deals 260
14.1.8.3.3 Other developments 262
14.1.8.4 MnM view 262
14.1.9 CRODA INTERNATIONAL PLC 263
14.1.9.1 Business overview 263
14.1.9.2 Products/Solutions/Services offered 264
14.1.9.3 MnM view 265
14.1.10 EVONIK INDUSTRIES AG 266
14.1.10.1 Business overview 266
14.1.10.2 Products/Solutions/Services offered 267
14.1.10.3 Recent developments 268
14.1.10.3.1 Product launches and enhancements 268
14.1.10.3.2 Deals 269
14.1.10.4 MnM view 269
14.1.11 PELAGIA AS 270
14.1.11.1 Business overview 270
14.1.11.2 Products/Solutions/Services offered 271
14.1.11.3 Recent developments 272
14.1.11.3.1 Product launches and enhancements 272
14.1.11.3.2 Other developments 272
14.1.11.4 MnM view 273
14.1.12 GC RIEBER 274
14.1.12.1 Business overview 274
14.1.12.2 Products/Solutions/Services offered 275
14.1.12.3 Recent developments 276
14.1.12.3.1 Product launches and enhancements 276
14.1.12.3.2 Deals 276
14.1.12.3.3 Expansions 277
14.1.12.4 MnM view 277
14.1.13 COOKE AQUACULTURE INC. 278
14.1.13.1 Business overview 278
14.1.13.2 Products/Solutions/Services offered 279
14.1.13.3 Recent developments 280
14.1.13.3.1 Deals 280
14.1.13.4 MnM view 280
14.1.14 ALGISYS BIOSCIENCES, INC. 281
14.1.14.1 Business overview 281
14.1.14.2 Products/Solutions/Services offered 281
14.1.14.3 Recent developments 282
14.1.14.3.1 Other developments 282
14.1.14.4 MnM view 282
14.1.15 POLARIS 283
14.1.15.1 Business overview 283
14.1.15.2 Products/Solutions/Services offered 283
14.1.15.3 Recent developments 284
14.1.15.3.1 Product launches and enhancements 284
14.1.15.3.2 Other developments 284
14.1.15.4 MnM view 284
14.2 OTHER PLAYERS 285
14.2.1 BTSA 285
14.2.1.1 Business overview 285
14.2.1.2 Products/Solutions/Services offered 285
14.2.1.3 MnM view 286
14.2.2 NOVOSANA EUROPE B.V. 287
14.2.2.1 Business overview 287
14.2.2.2 Products/Solutions/Services offered 287
14.2.2.3 Recent developments 288
14.2.2.3.1 Deals 288
14.2.2.4 MnM view 289
14.2.3 GOLDEN OMEGA 290
14.2.3.1 Business overview 290
14.2.3.2 Products/Solutions/Services offered 290
14.2.3.3 Recent developments 291
14.2.3.3.1 Deals 291
14.2.3.4 MnM view 291
14.2.4 KINOMEGA BIOPHARM INC. 292
14.2.4.1 Business overview 292
14.2.4.2 Products/Solutions/Services offered 292
14.2.4.3 MnM view 293
14.2.5 RIMFROST AS 294
14.2.5.1 Business overview 294
14.2.5.2 Products/Solutions/Services offered 294
14.2.5.3 Recent developments 295
14.2.5.3.1 Deals 295
14.2.5.4 MnM view 295
14.2.6 ALGARITHM 296
14.2.7 SOLUTEX 296
14.2.8 CELLANA INC. 297
14.2.9 SINOMEGA BIOTECH ENGINEERING CO., LTD. 297
14.2.10 ALGAECYTES LIMITED 298
15 ADJACENT & RELATED MARKETS 299
15.1 INTRODUCTION 299
15.2 STUDY LIMITATIONS 299
15.3 FUNCTIONAL FOOD INGREDIENTS MARKET 299
15.3.1 MARKET DEFINITION 299
15.3.2 MARKET OVERVIEW 300
15.4 COLLAGEN MARKET 301
15.4.1 MARKET DEFINITION 301
15.4.2 MARKET OVERVIEW 301
16 APPENDIX 303
16.1 DISCUSSION GUIDE 303
16.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 310
16.3 CUSTOMIZATION OPTIONS 312
16.4 RELATED REPORTS 312
16.5 AUTHOR DETAILS 313
LIST OF TABLES
TABLE 1 USD EXCHANGE RATES, 2020–2024 33
TABLE 2 OMEGA-3 MARKET SNAPSHOT, 2025 VS. 2030 (USD MILLION) 45
TABLE 3 HEALTH BENEFITS ASSOCIATED WITH OMEGA-3 CONSUMPTION 55
TABLE 4 INFANT FORMULA CONSTITUENTS OF KEY BRANDS (PER 100 GM) 57
TABLE 5 EPA AND DHA DAILY INTAKE GUIDELINES BY VARIOUS ORGANIZATIONS 62
TABLE 6 UPCOMING ALTERNATIVE SOURCES FOR OMEGA-3 FATTY ACIDS 63
TABLE 7 US ADJUSTED RECIPROCAL TARIFF RATES 75
TABLE 8 EXPECTED IMPACT LEVEL ON RAW MATERIALS AND INGREDIENTS WITH
RELEVANT HS CODES DUE TO US TARIFF IMPACT 76
TABLE 9 OMEGA-3 MARKET: EXPECTED TARIFF IMPACT ON APPLICATIONS 78
TABLE 10 IMPORT SCENARIO FOR HS CODE: 1504, BY COUNTRY, 2020–2024 (TONS) 82
TABLE 11 EXPORT SCENARIO FOR HS CODE: 1504, BY COUNTRY, 2020–2024 (TONS) 83
TABLE 12 AVERAGE SELLING PRICE OF OMEGA-3 FINISHED PRODUCTS, BY PRODUCT TYPE, 2024 (USD) 88
TABLE 13 AVERAGE SELLING PRICE TREND OF OMEGA-3, BY REGION,
2021–2024 (USD/TON) 89
TABLE 14 OMEGA-3 MARKET: ROLE OF COMPANIES IN ECOSYSTEM 91
TABLE 15 LIST OF MAJOR PATENTS PERTAINING TO OMEGA-3 MARKET, 2022–2025 94
TABLE 16 OMEGA-3 MARKET: LIST OF KEY CONFERENCES AND EVENTS, 2025–2026 95
TABLE 17 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 96
TABLE 18 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 96
TABLE 19 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 97
TABLE 20 SOUTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 97
TABLE 21 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 97
TABLE 22 IMPACT OF PORTER’S FIVE FORCES ON OMEGA-3 MARKET 102
TABLE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR KEY APPLICATIONS 105
TABLE 24 KEY CRITERIA FOR SELECTING SUPPLIERS/VENDORS 105
TABLE 25 OMEGA-3 MARKET, BY TYPE, 2021–2024 (USD MILLION) 110
TABLE 26 OMEGA-3 MARKET, BY TYPE, 2025–2030 (USD MILLION) 110
TABLE 27 FOOD SOURCES FOR DHA (GRAMS PER SERVING) 111
TABLE 28 DOCOSAHEXAENOIC ACID: OMEGA-3 MARKET, BY REGION,
2021–2024 (USD MILLION) 111
TABLE 29 DOCOSAHEXAENOIC ACID: OMEGA-3 MARKET, BY REGION,
2025–2030 (USD MILLION) 111
TABLE 30 FOOD SOURCES FOR EPA (GRAMS PER SERVING) 112
TABLE 31 EICOSAPENTAENOIC ACID: OMEGA-3 MARKET, BY REGION,
2021–2024 (USD MILLION) 113
TABLE 32 EICOSAPENTAENOIC ACID: OMEGA-3 MARKET, BY REGION,
2025–2030 (USD MILLION) 113
TABLE 33 FOOD SOURCES FOR ALA (GRAMS PER SERVING) 114
TABLE 34 ALPHA-LINOLENIC ACID: OMEGA-3 MARKET, BY REGION,
2021–2024 (USD MILLION) 114
TABLE 35 ALPHA-LINOLENIC ACID: OMEGA-3 MARKET, BY REGION,
2025–2030 (USD MILLION) 114
TABLE 36 OMEGA-3 MARKET, BY SOURCE, 2021–2024 (USD MILLION) 116
TABLE 37 OMEGA-3 MARKET, BY SOURCE, 2025–2030 (USD MILLION) 116
TABLE 38 OMEGA-3 MARKET, BY SOURCE, 2021–2024 (KILOTONS) 117
TABLE 39 OMEGA-3 MARKET, BY SOURCE, 2025–2030 (KILOTONS) 117
TABLE 40 MARINE-BASED FOOD SOURCES CONTAINING OMEGA-3 ACIDS 118
TABLE 41 MARINE: OMEGA-3 MARKET, BY REGION, 2021–2024 (USD MILLION) 118
TABLE 42 MARINE: OMEGA-3 MARKET, BY REGION, 2025–2030 (USD MILLION) 119
TABLE 43 MARINE: OMEGA-3 MARKET, BY REGION, 2021–2024 (KILOTONS) 119
TABLE 44 MARINE: OMEGA-3 MARKET, BY REGION, 2025–2030 (KILOTONS) 119
TABLE 45 MARINE: OMEGA-3 MARKET, BY SOURCE TYPE, 2021–2024 (USD MILLION) 120
TABLE 46 MARINE: OMEGA-3 MARKET, BY SOURCE TYPE, 2025–2030 (USD MILLION) 120
TABLE 47 FISH: OMEGA-3 MARKET, BY REGION, 2021–2024 (USD MILLION) 120
TABLE 48 FISH: OMEGA-3 MARKET, BY REGION, 2025–2030 (USD MILLION) 121
TABLE 49 ALGAE: OMEGA-3 MARKET, BY REGION, 2021–2024 (USD MILLION) 122
TABLE 50 ALGAE: OMEGA-3 MARKET, BY REGION, 2025–2030 (USD MILLION) 122
TABLE 51 KRILL: OMEGA-3 MARKET, BY REGION, 2021–2024 (USD MILLION) 124
TABLE 52 KRILL: OMEGA-3 MARKET, BY REGION, 2025–2030 (USD MILLION) 124
TABLE 53 OTHER MARINE SOURCES: OMEGA-3 MARKET, BY REGION,
2021–2024 (USD MILLION) 125
TABLE 54 OTHER MARINE SOURCES: OMEGA-3 MARKET, BY REGION,
2025–2030 (USD MILLION) 125
TABLE 55 PLANT: OMEGA-3 MARKET, BY REGION, 2021–2024 (USD MILLION) 126
TABLE 56 PLANT: OMEGA-3 MARKET, BY REGION, 2025–2030 (USD MILLION) 126
TABLE 57 PLANT: OMEGA-3 MARKET, BY REGION, 2021–2024 (KILOTONS) 126
TABLE 58 PLANT: OMEGA-3 MARKET, BY REGION, 2025–2030 (KILOTONS) 127
TABLE 59 PLANT: OMEGA-3 MARKET, BY SOURCE TYPE, 2021–2024 (USD MILLION) 127
TABLE 60 PLANT: OMEGA-3 MARKET, BY SOURCE TYPE, 2025–2030 (USD MILLION) 127
TABLE 61 NUTS & SEEDS: OMEGA-3 MARKET, BY REGION, 2021–2024 (USD MILLION) 128
TABLE 62 NUTS & SEEDS: OMEGA-3 MARKET, BY REGION, 2025–2030 (USD MILLION) 128
TABLE 63 VEGETABLE OILS: OMEGA-3 MARKET, BY REGION, 2021–2024 (USD MILLION) 129
TABLE 64 VEGETABLE OILS: OMEGA-3 MARKET, BY REGION, 2025–2030 (USD MILLION) 129
TABLE 65 OMEGA-3 MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 131
TABLE 66 OMEGA-3 MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 132
TABLE 67 DIETARY SUPPLEMENTS: OMEGA-3 MARKET, BY REGION,
2021–2024 (USD MILLION) 133
TABLE 68 DIETARY SUPPLEMENTS: OMEGA-3 MARKET, BY REGION,
2025–2030 (USD MILLION) 133
TABLE 69 FUNCTIONAL FOODS & BEVERAGES: OMEGA-3 MARKET, BY REGION,
2021–2024 (USD MILLION) 134
TABLE 70 FUNCTIONAL FOODS & BEVERAGES: OMEGA-3 MARKET, BY REGION,
2025–2030 (USD MILLION) 134
TABLE 71 PHARMACEUTICALS: OMEGA-3 MARKET, BY REGION, 2021–2024 (USD MILLION) 136
TABLE 72 PHARMACEUTICALS: OMEGA-3 MARKET, BY REGION, 2025–2030 (USD MILLION) 137
TABLE 73 INFANT FORMULAS: OMEGA-3 MARKET, BY REGION, 2021–2024 (USD MILLION) 137
TABLE 74 INFANT FORMULAS: OMEGA-3 MARKET, BY REGION, 2025–2030 (USD MILLION) 138
TABLE 75 PET FOOD & FEED: OMEGA-3 MARKET, BY REGION, 2021–2024 (USD MILLION) 138
TABLE 76 PET FOOD & FEED: OMEGA-3 MARKET, BY REGION, 2025–2030 (USD MILLION) 139
TABLE 77 OMEGA-3 MARKET, BY FORM, 2021–2024 (USD MILLION) 141
TABLE 78 OMEGA-3 MARKET, BY FORM, 2025–2030 (USD MILLION) 141
TABLE 79 DRY: OMEGA-3 MARKET, BY REGION, 2021–2024 (USD MILLION) 142
TABLE 80 DRY: OMEGA-3 MARKET, BY REGION, 2025–2030 (USD MILLION) 142
TABLE 81 LIQUID: OMEGA-3 MARKET, BY REGION, 2021–2024 (USD MILLION) 143
TABLE 82 LIQUID: OMEGA-3 MARKET, BY REGION, 2025–2030 (USD MILLION) 144
TABLE 83 OMEGA-3 MARKET, BY REGION, 2021–2024 (USD MILLION) 149
TABLE 84 OMEGA-3 MARKET, BY REGION, 2025–2030 (USD MILLION) 150
TABLE 85 OMEGA-3 MARKET, BY REGION, 2021–2024 (KILOTONS) 150
TABLE 86 OMEGA-3 MARKET, BY REGION, 2025–2030 (KILOTONS) 150
TABLE 87 NORTH AMERICA: OMEGA-3 MARKET, BY COUNTRY, 2021–2024 (USD MILLION) 152
TABLE 88 NORTH AMERICA: OMEGA-3 MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 152
TABLE 89 NORTH AMERICA: OMEGA-3 MARKET, BY TYPE, 2021–2024 (USD MILLION) 153
TABLE 90 NORTH AMERICA: OMEGA-3 MARKET, BY TYPE, 2025–2030 (USD MILLION) 153
TABLE 91 NORTH AMERICA: OMEGA-3 MARKET, BY APPLICATION,
2021–2024 (USD MILLION) 153
TABLE 92 NORTH AMERICA: OMEGA-3 MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 153
TABLE 93 NORTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2021–2024 (USD MILLION) 154
TABLE 94 NORTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2025–2030 (USD MILLION) 154
TABLE 95 NORTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2021–2024 (KILOTONS) 154
TABLE 96 NORTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2025–2030 (KILOTONS) 154
TABLE 97 NORTH AMERICA: MARINE OMEGA-3 MARKET, BY SOURCE TYPE,
2021–2024 (USD MILLION) 155
TABLE 98 NORTH AMERICA: MARINE OMEGA-3 MARKET, BY SOURCE TYPE,
2025–2030 (USD MILLION) 155
TABLE 99 NORTH AMERICA: PLANT OMEGA-3 MARKET, BY SOURCE TYPE,
2021–2024 (USD MILLION) 155
TABLE 100 NORTH AMERICA: PLANT OMEGA-3 MARKET, BY SOURCE TYPE,
2025–2030 (USD MILLION) 155
TABLE 101 US: OMEGA-3 MARKET, BY TYPE, 2021–2024 (USD MILLION) 156
TABLE 102 US: OMEGA-3 MARKET, BY TYPE, 2025–2030 (USD MILLION) 156
TABLE 103 US: OMEGA-3 MARKET, BY SOURCE, 2021–2024 (USD MILLION) 157
TABLE 104 US: OMEGA-3 MARKET, BY SOURCE, 2025–2030 (USD MILLION) 157
TABLE 105 CANADA: OMEGA-3 MARKET, BY TYPE, 2021–2024 (USD MILLION) 158
TABLE 106 CANADA: OMEGA-3 MARKET, BY TYPE, 2025–2030 (USD MILLION) 158
TABLE 107 CANADA: OMEGA-3 MARKET, BY SOURCE, 2021–2024 (USD MILLION) 158
TABLE 108 CANADA: OMEGA-3 MARKET, BY SOURCE, 2025–2030 (USD MILLION) 158
TABLE 109 MEXICO: OMEGA-3 MARKET, BY TYPE, 2021–2024 (USD MILLION) 159
TABLE 110 MEXICO: OMEGA-3 MARKET, BY TYPE, 2025–2030 (USD MILLION) 160
TABLE 111 MEXICO: OMEGA-3 MARKET, BY SOURCE, 2021–2024 (USD MILLION) 160
TABLE 112 MEXICO: OMEGA-3 MARKET, BY SOURCE, 2025–2030 (USD MILLION) 160
TABLE 113 EUROPE: OMEGA-3 MARKET, BY COUNTRY, 2021–2024 (USD MILLION) 161
TABLE 114 EUROPE: OMEGA-3 MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 162
TABLE 115 EUROPE: OMEGA-3 MARKET, BY TYPE, 2021–2024 (USD MILLION) 162
TABLE 116 EUROPE: OMEGA-3 MARKET, BY TYPE, 2025–2030 (USD MILLION) 162
TABLE 117 EUROPE: OMEGA-3 MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 163
TABLE 118 EUROPE: OMEGA-3 MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 163
TABLE 119 EUROPE: OMEGA-3 MARKET, BY SOURCE, 2021–2024 (USD MILLION) 163
TABLE 120 EUROPE: OMEGA-3 MARKET, BY SOURCE, 2025–2030 (USD MILLION) 163
TABLE 121 EUROPE: OMEGA-3 MARKET, BY SOURCE, 2021–2024 (KILOTONS) 164
TABLE 122 EUROPE: OMEGA-3 MARKET, BY SOURCE, 2025–2030 (KILOTONS) 164
TABLE 123 EUROPE: MARINE OMEGA-3 MARKET, BY SOURCE TYPE,
2021–2024 (USD MILLION) 164
TABLE 124 EUROPE: MARINE OMEGA-3 MARKET, BY SOURCE TYPE,
2025–2030 (USD MILLION) 164
TABLE 125 EUROPE: PLANT OMEGA-3 MARKET, BY SOURCE TYPE, 2021–2024 (USD MILLION) 165
TABLE 126 EUROPE: PLANT OMEGA-3 MARKET, BY SOURCE TYPE, 2025–2030 (USD MILLION) 165
TABLE 127 GERMANY: OMEGA-3 MARKET, BY TYPE, 2021–2024 (USD MILLION) 165
TABLE 128 GERMANY: OMEGA-3 MARKET, BY TYPE, 2025–2030 (USD MILLION) 166
TABLE 129 GERMANY: OMEGA-3 MARKET, BY SOURCE, 2021–2024 (USD MILLION) 166
TABLE 130 GERMANY: OMEGA-3 MARKET, BY SOURCE, 2025–2030 (USD MILLION) 166
TABLE 131 UK: OMEGA-3 MARKET, BY TYPE, 2021–2024 (USD MILLION) 167
TABLE 132 UK: OMEGA-3 MARKET, BY TYPE, 2025–2030 (USD MILLION) 167
TABLE 133 UK: OMEGA-3 MARKET, BY SOURCE, 2021–2024 (USD MILLION) 167
TABLE 134 UK: OMEGA-3 MARKET, BY SOURCE, 2025–2030 (USD MILLION) 168
TABLE 135 FRANCE: OMEGA-3 MARKET, BY TYPE, 2021–2024 (USD MILLION) 168
TABLE 136 FRANCE: OMEGA-3 MARKET, BY TYPE, 2025–2030 (USD MILLION) 169
TABLE 137 FRANCE: OMEGA-3 MARKET, BY SOURCE, 2021–2024 (USD MILLION) 169
TABLE 138 FRANCE: OMEGA-3 MARKET, BY SOURCE, 2025–2030 (USD MILLION) 169
TABLE 139 NORWAY: OMEGA-3 MARKET, BY TYPE, 2021–2024 (USD MILLION) 170
TABLE 140 NORWAY: OMEGA-3 MARKET, BY TYPE, 2025–2030 (USD MILLION) 170
TABLE 141 NORWAY: OMEGA-3 MARKET, BY SOURCE, 2021–2024 (USD MILLION) 170
TABLE 142 NORWAY: OMEGA-3 MARKET, BY SOURCE, 2025–2030 (USD MILLION) 170
TABLE 143 ITALY: OMEGA-3 MARKET, BY TYPE, 2021–2024 (USD MILLION) 171
TABLE 144 ITALY: OMEGA-3 MARKET, BY TYPE, 2025–2030 (USD MILLION) 172
TABLE 145 ITALY: OMEGA-3 MARKET, BY SOURCE, 2021–2024 (USD MILLION) 172
TABLE 146 ITALY: OMEGA-3 MARKET, BY SOURCE, 2025–2030 (USD MILLION) 172
TABLE 147 SPAIN: OMEGA-3 MARKET, BY TYPE, 2021–2024 (USD MILLION) 173
TABLE 148 SPAIN: OMEGA-3 MARKET, BY TYPE, 2025–2030 (USD MILLION) 173
TABLE 149 SPAIN: OMEGA-3 MARKET, BY SOURCE, 2021–2024 (USD MILLION) 173
TABLE 150 SPAIN: OMEGA-3 MARKET, BY SOURCE, 2025–2030 (USD MILLION) 173
TABLE 151 NETHERLANDS: OMEGA-3 MARKET, BY TYPE, 2021–2024 (USD MILLION) 174
TABLE 152 NETHERLANDS: OMEGA-3 MARKET, BY TYPE, 2025–2030 (USD MILLION) 174
TABLE 153 NETHERLANDS: OMEGA-3 MARKET, BY SOURCE, 2021–2024 (USD MILLION) 175
TABLE 154 NETHERLANDS: OMEGA-3 MARKET, BY SOURCE, 2025–2030 (USD MILLION) 175
TABLE 155 REST OF EUROPE: OMEGA-3 MARKET, BY TYPE, 2021–2024 (USD MILLION) 175
TABLE 156 REST OF EUROPE: OMEGA-3 MARKET, BY TYPE, 2025–2030 (USD MILLION) 176
TABLE 157 REST OF EUROPE: OMEGA-3 MARKET, BY SOURCE, 2021–2024 (USD MILLION) 176
TABLE 158 REST OF EUROPE: OMEGA-3 MARKET, BY SOURCE, 2025–2030 (USD MILLION) 176
TABLE 159 ASIA PACIFIC: OMEGA-3 MARKET, BY COUNTRY, 2021–2024 (USD MILLION) 178
TABLE 160 ASIA PACIFIC: OMEGA-3 MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 179
TABLE 161 ASIA PACIFIC: OMEGA-3 MARKET, BY TYPE, 2021–2024 (USD MILLION) 179
TABLE 162 ASIA PACIFIC: OMEGA-3 MARKET, BY TYPE, 2025–2030 (USD MILLION) 179
TABLE 163 ASIA PACIFIC: OMEGA-3 MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 180
TABLE 164 ASIA PACIFIC: OMEGA-3 MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 180
TABLE 165 ASIA PACIFIC: OMEGA-3 MARKET, BY SOURCE, 2021–2024 (USD MILLION) 180
TABLE 166 ASIA PACIFIC: OMEGA-3 MARKET, BY SOURCE, 2025–2030 (USD MILLION) 180
TABLE 167 ASIA PACIFIC: OMEGA-3 MARKET, BY SOURCE, 2021–2024 (KILOTONS) 181
TABLE 168 ASIA PACIFIC: OMEGA-3 MARKET, BY SOURCE, 2025–2030 (KILOTONS) 181
TABLE 169 ASIA PACIFIC: MARINE OMEGA-3 MARKET, BY SOURCE TYPE,
2021–2024 (USD MILLION) 181
TABLE 170 ASIA PACIFIC: MARINE OMEGA-3 MARKET, BY SOURCE TYPE,
2025–2030 (USD MILLION) 181
TABLE 171 ASIA PACIFIC: PLANT OMEGA-3 MARKET, BY SOURCE TYPE,
2021–2024 (USD MILLION) 182
TABLE 172 ASIA PACIFIC: PLANT OMEGA-3 MARKET, BY SOURCE TYPE,
2025–2030 (USD MILLION) 182
TABLE 173 CHINA: OMEGA-3 MARKET, BY TYPE, 2021–2024 (USD MILLION) 183
TABLE 174 CHINA: OMEGA-3 MARKET, BY TYPE, 2025–2030 (USD MILLION) 183
TABLE 175 CHINA: OMEGA-3 MARKET, BY SOURCE, 2021–2024 (USD MILLION) 183
TABLE 176 CHINA: OMEGA-3 MARKET, BY SOURCE, 2025–2030 (USD MILLION) 183
TABLE 177 INDIA: OMEGA-3 MARKET, BY TYPE, 2021–2024 (USD MILLION) 184
TABLE 178 INDIA: OMEGA-3 MARKET, BY TYPE, 2025–2030 (USD MILLION) 184
TABLE 179 INDIA: OMEGA-3 MARKET, BY SOURCE, 2021–2024 (USD MILLION) 184
TABLE 180 INDIA: OMEGA-3 MARKET, BY SOURCE, 2025–2030 (USD MILLION) 185
TABLE 181 JAPAN: OMEGA-3 MARKET, BY TYPE, 2021–2024 (USD MILLION) 185
TABLE 182 JAPAN: OMEGA-3 MARKET, BY TYPE, 2025–2030 (USD MILLION) 186
TABLE 183 JAPAN: OMEGA-3 MARKET, BY SOURCE, 2021–2024 (USD MILLION) 186
TABLE 184 JAPAN: OMEGA-3 MARKET, BY SOURCE, 2025–2030 (USD MILLION) 186
TABLE 185 AUSTRALIA & NEW ZEALAND: OMEGA-3 MARKET, BY TYPE,
2021–2024 (USD MILLION) 187
TABLE 186 AUSTRALIA & NEW ZEALAND: OMEGA-3 MARKET, BY TYPE,
2025–2030 (USD MILLION) 187
TABLE 187 AUSTRALIA & NEW ZEALAND: OMEGA-3 MARKET, BY SOURCE,
2021–2024 (USD MILLION) 188
TABLE 188 AUSTRALIA & NEW ZEALAND: OMEGA-3 MARKET, BY SOURCE,
2025–2030 (USD MILLION) 188
TABLE 189 REST OF ASIA PACIFIC: OMEGA-3 MARKET, BY TYPE, 2021–2024 (USD MILLION) 189
TABLE 190 REST OF ASIA PACIFIC: OMEGA-3 MARKET, BY TYPE, 2025–2030 (USD MILLION) 189
TABLE 191 REST OF ASIA PACIFIC: OMEGA-3 MARKET, BY SOURCE,
2021–2024 (USD MILLION) 189
TABLE 192 REST OF ASIA PACIFIC: OMEGA-3 MARKET, BY SOURCE,
2025–2030 (USD MILLION) 189
TABLE 193 SOUTH AMERICA: OMEGA-3 MARKET, BY COUNTRY, 2021–2024 (USD MILLION) 190
TABLE 194 SOUTH AMERICA: OMEGA-3 MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 190
TABLE 195 SOUTH AMERICA: OMEGA-3 MARKET, BY TYPE, 2021–2024 (USD MILLION) 190
TABLE 196 SOUTH AMERICA: OMEGA-3 MARKET, BY TYPE, 2025–2030 (USD MILLION) 191
TABLE 197 SOUTH AMERICA: OMEGA-3 MARKET, BY APPLICATION,
2021–2024 (USD MILLION) 191
TABLE 198 SOUTH AMERICA: OMEGA-3 MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 191
TABLE 199 SOUTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2021–2024 (USD MILLION) 191
TABLE 200 SOUTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2025–2030 (USD MILLION) 192
TABLE 201 SOUTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2021–2024 (KILOTONS) 192
TABLE 202 SOUTH AMERICA: OMEGA-3 MARKET, BY SOURCE, 2025–2030 (KILOTONS) 192
TABLE 203 SOUTH AMERICA: MARINE OMEGA-3 MARKET, BY SOURCE TYPE,
2021–2024 (USD MILLION) 192
TABLE 204 SOUTH AMERICA: MARINE OMEGA-3 MARKET, BY SOURCE TYPE,
2025–2030 (USD MILLION) 193
TABLE 205 SOUTH AMERICA: PLANT OMEGA-3 MARKET, BY SOURCE TYPE,
2021–2024 (USD MILLION) 193
TABLE 206 SOUTH AMERICA: PLANT OMEGA-3 MARKET, BY SOURCE TYPE,
2025–2030 (USD MILLION) 193
TABLE 207 BRAZIL: OMEGA-3 MARKET, BY TYPE, 2021–2024 (USD MILLION) 194
TABLE 208 BRAZIL: OMEGA-3 MARKET, BY TYPE, 2025–2030 (USD MILLION) 194
TABLE 209 BRAZIL: OMEGA-3 MARKET, BY SOURCE, 2021–2024 (USD MILLION) 194
TABLE 210 BRAZIL: OMEGA-3 MARKET, BY SOURCE, 2025–2030 (USD MILLION) 195
TABLE 211 ARGENTINA: OMEGA-3 MARKET, BY TYPE, 2021–2024 (USD MILLION) 195
TABLE 212 ARGENTINA: OMEGA-3 MARKET, BY TYPE, 2025–2030 (USD MILLION) 195
TABLE 213 ARGENTINA: OMEGA-3 MARKET, BY SOURCE, 2021–2024 (USD MILLION) 196
TABLE 214 ARGENTINA: OMEGA-3 MARKET, BY SOURCE, 2025–2030 (USD MILLION) 196
TABLE 215 REST OF SOUTH AMERICA: OMEGA-3 MARKET, BY TYPE,
2021–2024 (USD MILLION) 196
TABLE 216 REST OF SOUTH AMERICA: OMEGA-3 MARKET, BY TYPE,
2025–2030 (USD MILLION) 196
TABLE 217 REST OF SOUTH AMERICA: OMEGA-3 MARKET, BY SOURCE,
2021–2024 (USD MILLION) 197
TABLE 218 REST OF SOUTH AMERICA: OMEGA-3 MARKET, BY SOURCE,
2025–2030 (USD MILLION) 197
TABLE 219 REST OF THE WORLD: OMEGA-3 MARKET, BY REGION, 2021–2024 (USD MILLION) 197
TABLE 220 REST OF THE WORLD: OMEGA-3 MARKET, BY REGION, 2025–2030 (USD MILLION) 198
TABLE 221 REST OF THE WORLD: OMEGA-3 MARKET, BY TYPE, 2021–2024 (USD MILLION) 198
TABLE 222 REST OF THE WORLD: OMEGA-3 MARKET, BY TYPE, 2025–2030 (USD MILLION) 198
TABLE 223 REST OF THE WORLD: OMEGA-3 MARKET, BY APPLICATION,
2021–2024 (USD MILLION) 198
TABLE 224 REST OF THE WORLD: OMEGA-3 MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 199
TABLE 225 REST OF THE WORLD: OMEGA-3 MARKET, BY SOURCE, 2021–2024 (USD MILLION) 199
TABLE 226 REST OF THE WORLD: OMEGA-3 MARKET, BY SOURCE, 2025–2030 (USD MILLION) 199
TABLE 227 REST OF THE WORLD: OMEGA-3 MARKET, BY SOURCE, 2021–2024 (KILOTONS) 199
TABLE 228 REST OF THE WORLD: OMEGA-3 MARKET, BY SOURCE, 2025–2030 (KILOTONS) 200
TABLE 229 REST OF THE WORLD: MARINE OMEGA-3 MARKET, BY SOURCE TYPE,
2021–2024 (USD MILLION) 200
TABLE 230 REST OF THE WORLD: MARINE OMEGA-3 MARKET, BY SOURCE TYPE,
2025–2030 (USD MILLION) 200
TABLE 231 REST OF THE WORLD: PLANT OMEGA-3 MARKET, BY SOURCE TYPE,
2021–2024 (USD MILLION) 200
TABLE 232 REST OF THE WORLD: PLANT OMEGA-3 MARKET, BY SOURCE TYPE,
2025–2030 (USD MILLION) 201
TABLE 233 AFRICA: OMEGA-3 MARKET, BY TYPE, 2021–2024 (USD MILLION) 201
TABLE 234 AFRICA: OMEGA-3 MARKET, BY TYPE, 2025–2030 (USD MILLION) 202
TABLE 235 AFRICA: OMEGA-3 MARKET, BY SOURCE, 2021–2024 (USD MILLION) 202
TABLE 236 AFRICA: OMEGA-3 MARKET, BY SOURCE, 2025–2030 (USD MILLION) 202
TABLE 237 MIDDLE EAST: OMEGA-3 MARKET, BY TYPE, 2021–2024 (USD MILLION) 203
TABLE 238 MIDDLE EAST: OMEGA-3 MARKET, BY TYPE, 2025–2030 (USD MILLION) 203
TABLE 239 MIDDLE EAST: OMEGA-3 MARKET, BY SOURCE, 2021–2024 (USD MILLION) 203
TABLE 240 MIDDLE EAST: OMEGA-3 MARKET, BY SOURCE, 2025–2030 (USD MILLION) 203
TABLE 241 OVERVIEW OF STRATEGIES ADOPTED BY KEY OMEGA-3 MARKET PLAYERS,
2020–2024 205
TABLE 242 OMEGA-3 MARKET: DEGREE OF COMPETITION, 2024 208
TABLE 243 OMEGA-3 MARKET: REGIONAL FOOTPRINT 216
TABLE 244 OMEGA-3 MARKET: SOURCE FOOTPRINT 217
TABLE 245 OMEGA-3 MARKET: TYPE FOOTPRINT 217
TABLE 246 OMEGA-3 MARKET: APPLICATION FOOTPRINT 218
TABLE 247 OMEGA-3 MARKET: KEY STARTUPS/SMES 221
TABLE 248 OMEGA-3 MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES 222
TABLE 249 OMEGA-3 MARKET: PRODUCT LAUNCHES AND ENHANCEMENTS,
2020–AUGUST 2025 223
TABLE 250 OMEGA-3 MARKET: DEALS, 2020–AUGUST 2025 225
TABLE 251 OMEGA-3 MARKET: EXPANSIONS, 2020–AUGUST 2025 230
TABLE 252 DSM-FIRMENICH: COMPANY OVERVIEW 232
TABLE 253 DSM-FIRMENICH: PRODUCTS/SOLUTIONS/SERVICES OFFERED 233
TABLE 254 DSM-FIRMENICH: PRODUCT LAUNCHES AND ENHANCEMENTS 234
TABLE 255 CARGILL, INCORPORATED: COMPANY OVERVIEW 235
TABLE 256 CARGILL, INCORPORATED: PRODUCTS/SOLUTIONS/SERVICES OFFERED 236
TABLE 257 CARGILL, INCORPORATED: DEALS 236
TABLE 258 BASF SE: COMPANY OVERVIEW 238
TABLE 259 BASF SE: PRODUCTS/SOLUTIONS/SERVICES OFFERED 239
TABLE 260 ADM: COMPANY OVERVIEW 242
TABLE 261 ADM: PRODUCTS/SOLUTIONS/SERVICES OFFERED 243
TABLE 262 KERRY GROUP PLC: COMPANY OVERVIEW 245
TABLE 263 KERRY GROUP PLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED 246
TABLE 264 KERRY GROUP PLC: DEALS 247
TABLE 265 CORBION: COMPANY OVERVIEW 249
TABLE 266 CORBION: PRODUCTS/SOLUTIONS/SERVICES OFFERED 250
TABLE 267 CORBION: PRODUCT LAUNCHES AND ENHANCEMENTS 251
TABLE 268 CORBION: EXPANSIONS 251
TABLE 269 CORBION: OTHER DEVELOPMENTS 252
TABLE 270 KD PHARMA GROUP SA: COMPANY OVERVIEW 253
TABLE 271 KD PHARMA GROUP SA: PRODUCTS/SOLUTIONS/SERVICES OFFERED 254
TABLE 272 KD PHARMA GROUP SA: DEALS 255
TABLE 273 KD PHARMA GROUP SA: EXPANSIONS 256
TABLE 274 AKER BIOMARINE: COMPANY OVERVIEW 257
TABLE 275 AKER BIOMARINE: PRODUCTS/SOLUTIONS/SERVICES OFFERED 258
TABLE 276 AKER BIOMARINE: PRODUCT LAUNCHES AND ENHANCEMENTS 259
TABLE 277 AKER BIOMARINE: DEALS 260
TABLE 278 AKER BIOMARINE: OTHER DEVELOPMENTS 262
TABLE 279 CRODA INTERNATIONAL PLC: COMPANY OVERVIEW 263
TABLE 280 CRODA INTERNATIONAL PLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED 264
TABLE 281 EVONIK INDUSTRIES AG: COMPANY OVERVIEW 266
TABLE 282 EVONIK INDUSTRIES AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED 267
TABLE 283 EVONIK INDUSTRIES AG: PRODUCT LAUNCHES AND ENHANCEMENTS 268
TABLE 284 EVONIK INDUSTRIES AG: DEALS 269
TABLE 285 PELAGIA AS: COMPANY OVERVIEW 270
TABLE 286 PELAGIA AS: PRODUCTS/SOLUTIONS/SERVICES OFFERED 271
TABLE 287 PELAGIA AS: PRODUCT LAUNCHES AND ENHANCEMENTS 272
TABLE 288 PELAGIA AS: OTHER DEVELOPMENTS 272
TABLE 289 GC RIEBER: COMPANY OVERVIEW 274
TABLE 290 GC RIEBER: PRODUCTS/SOLUTIONS/SERVICES OFFERED 275
TABLE 291 GC RIEBER: PRODUCT LAUNCHES AND ENHANCEMENTS 276
TABLE 292 GC REIBER: DEALS 276
TABLE 293 GC RIEBER: EXPANSIONS 277
TABLE 294 COOKE AQUACULTURE INC.: COMPANY OVERVIEW 278
TABLE 295 COOKE AQUACULTURE INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 279
TABLE 296 COOKE AQUACULTURE INC.: DEALS 280
TABLE 297 ALGISYS BIOSCIENCES, INC.: COMPANY OVERVIEW 281
TABLE 298 ALGISYS BIOSCIENCES, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 281
TABLE 299 ALGISYS BIOSCIENCES, INC.: OTHER DEVELOPMENTS 282
TABLE 300 POLARIS: COMPANY OVERVIEW 283
TABLE 301 POLARIS: PRODUCTS/SOLUTIONS/SERVICES OFFERED 283
TABLE 302 POLARIS: PRODUCT LAUNCHES AND ENHANCEMENTS 284
TABLE 303 POLARIS: OTHER DEVELOPMENTS 284
TABLE 304 BTSA: COMPANY OVERVIEW 285
TABLE 305 BTSA: PRODUCTS/SOLUTIONS/SERVICES OFFERED 285
TABLE 306 NOVOSANA EUROPE B.V.: COMPANY OVERVIEW 287
TABLE 307 NOVOSANA EUROPE B.V.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 287
TABLE 308 NOVOSANA EUROPE B.V.: DEALS 288
TABLE 309 GOLDEN OMEGA: COMPANY OVERVIEW 290
TABLE 310 GOLDEN OMEGA: PRODUCTS/SOLUTIONS/SERVICES OFFERED 290
TABLE 311 GOLDEN OMEGA: DEALS 291
TABLE 312 KINOMEGA BIOPHARM INC.: COMPANY OVERVIEW 292
TABLE 313 KINOMEGA BIOPHARM INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 292
TABLE 314 RIMFROST AS: COMPANY OVERVIEW 294
TABLE 315 RIMFROST AS: PRODUCTS/SOLUTIONS/SERVICES OFFERED 294
TABLE 316 RIMFROST AS: DEALS 295
TABLE 317 MARKETS ADJACENT TO OMEGA-3 MARKET 299
TABLE 318 FUNCTIONAL FOOD INGREDIENTS MARKET, BY SOURCE,
2019–2023 (USD MILLION) 300
TABLE 319 FUNCTIONAL FOOD INGREDIENTS MARKET, BY SOURCE,
2024–2029 (USD MILLION) 300
TABLE 320 COLLAGEN MARKET, BY FORM, 2019–2022 (USD MILLION) 302
TABLE 321 COLLAGEN MARKET, BY FORM, 2023–2030 (USD MILLION) 302
LIST OF FIGURES
FIGURE 1 OMEGA-3 MARKET: RESEARCH DESIGN 35
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,
AND REGION 37
FIGURE 3 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 39
FIGURE 4 SUPPLY-SIDE ANALYSIS: SOURCES OF INFORMATION AT EVERY STEP 40
FIGURE 5 OMEGA-3 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 41
FIGURE 6 DATA TRIANGULATION 42
FIGURE 7 OMEGA-3 MARKET, BY SOURCE, 2025 VS. 2030 (USD MILLION) 45
FIGURE 8 OMEGA-3 MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION) 46
FIGURE 9 OMEGA-3 MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION) 46
FIGURE 10 OMEGA-3 MARKET SHARE AND GROWTH RATE, BY REGION, 2025 (VALUE) 47
FIGURE 11 RISING HEALTH AWARENESS AND PREVENTIVE NUTRITION TO DRIVE MARKET 48
FIGURE 12 MARINE SEGMENT AND US TO ACCOUNT FOR LARGEST MARKET SHARES IN NORTH AMERICA IN 2025 48
FIGURE 13 DHA SEGMENT TO LEAD MARKET DURING FORECAST PERIOD 49
FIGURE 14 DIETARY SUPPLEMENTS APPLICATION TO LEAD MARKET DURING
FORECAST PERIOD 49
FIGURE 15 MARINE SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 50
FIGURE 16 US TO RECORD LARGEST MARKET SHARE IN 2025 51
FIGURE 17 PREVENTIVE HEALTHCARE EXPENDITURE AS PERCENTAGE OF GDP,
BY COUNTRY, 2022 53
FIGURE 18 GLOBAL POPULATION AGED 65 AND ABOVE (% OF TOTAL POPULATION),
2014–2024 54
FIGURE 19 OMEGA-3 MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 54
FIGURE 20 RECOMMENDED EPA LEVELS IN DOG FOOD (MG) 59
FIGURE 21 MICROALGAE PROCESSING FOR OMEGA-3 64
FIGURE 22 ADOPTION OF GEN AI IN FOOD & BEVERAGE PRODUCTION PROCESS 69
FIGURE 23 OMEGA-3 MARKET: VALUE CHAIN ANALYSIS 80
FIGURE 24 IMPORT OF HS CODE 1504, BY KEY COUNTRY, 2020–2024 (TONS) 82
FIGURE 25 EXPORT OF HS CODE 1504, BY KEY COUNTRY, 2020–2024 (TONS) 83
FIGURE 26 AVERAGE SELLING PRICE OF OMEGA-3 FINISHED PRODUCTS,
BY PRODUCT TYPE, 2024 (USD) 87
FIGURE 27 AVERAGE SELLING PRICE TREND OF OMEGA-3, BY REGION,
2021–2024 (USD/TON) 88
FIGURE 28 OMEGA-3 MARKET: ECOSYSTEM ANALYSIS 90
FIGURE 29 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 92
FIGURE 30 KEY PATENTS APPLIED AND GRANTED, 2015–2025 93
FIGURE 31 REGIONAL ANALYSIS OF PATENTS GRANTED IN OMEGA-3 MARKET, 2015–2025 95
FIGURE 32 OMEGA-3 MARKET: PORTER’S FIVE FORCES ANALYSIS 102
FIGURE 33 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR KEY APPLICATIONS 104
FIGURE 34 KEY CRITERIA FOR SELECTING SUPPLIERS/VENDORS 105
FIGURE 35 OMEGA-3 MARKET: INVESTOR DEALS AND FUNDING 107
FIGURE 36 OMEGA-3 MARKET, BY TYPE, 2025 VS. 2030 (USD MILLION) 109
FIGURE 37 OMEGA-3 MARKET, BY SOURCE, 2025 VS. 2030 (USD MILLION) 116
FIGURE 38 OMEGA-3 MARKET, BY APPLICATION, 2025 VS. 2030 (USD MILLION) 131
FIGURE 39 OMEGA-3 MARKET, BY FORM, 2025 VS. 2030 (USD MILLION) 141
FIGURE 40 INDIA TO RECORD HIGHEST GROWTH RATE IN OMEGA-3 MARKET 149
FIGURE 41 NORTH AMERICA: REGIONAL SNAPSHOT 152
FIGURE 42 ASIA PACIFIC: REGIONAL SNAPSHOT 178
FIGURE 43 REVENUE ANALYSIS OF KEY PLAYERS, 2022–2024 (USD BILLION) 207
FIGURE 44 SHARE ANALYSIS OF OMEGA-3 MARKET, 2024 208
FIGURE 45 COMPANY VALUATION FOR MAJOR PLAYERS IN OMEGA-3 MARKET 210
FIGURE 46 EV/EBITDA OF MAJOR PLAYERS 210
FIGURE 47 OMEGA-3 MARKET: BRAND/PRODUCT COMPARISON 211
FIGURE 48 OMEGA-3 MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 214
FIGURE 49 OMEGA-3 MARKET: COMPANY FOOTPRINT 215
FIGURE 50 OMEGA-3 MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 220
FIGURE 51 DSM-FIRMENICH: COMPANY SNAPSHOT 233
FIGURE 52 CARGILL, INCORPORATED: COMPANY SNAPSHOT 236
FIGURE 53 BASF SE: COMPANY SNAPSHOT 239
FIGURE 54 ADM: COMPANY SNAPSHOT 243
FIGURE 55 KERRY GROUP PLC: COMPANY SNAPSHOT 246
FIGURE 56 CORBION: COMPANY SNAPSHOT 250
FIGURE 57 AKER BIOMARINE: COMPANY SNAPSHOT 258
FIGURE 58 CRODA INTERNATIONAL PLC: COMPANY SNAPSHOT 264
FIGURE 59 EVONIK INDUSTRIES AG: COMPANY SNAPSHOT 267
FIGURE 60 PELAGIA AS: COMPANY SNAPSHOT 271
FIGURE 61 GC RIEBER: COMPANY SNAPSHOT 275
